UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023971
Receipt number R000024966
Scientific Title Disturbance of autonomic nervous function in the severe cases of intracranial hypotension
Date of disclosure of the study information 2016/09/08
Last modified on 2021/03/12 14:29:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Disturbance of autonomic nervous function in the severe cases of intracranial hypotension

Acronym

Disturbance of autonomic nervous function in the severe cases of intracranial hypotension

Scientific Title

Disturbance of autonomic nervous function in the severe cases of intracranial hypotension

Scientific Title:Acronym

Disturbance of autonomic nervous function in the severe cases of intracranial hypotension

Region

Japan


Condition

Condition

intracranial hypotension

Classification by specialty

Medicine in general Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the autonomic nervous function in the severe cases of intracranial hypotension

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

autonomic nervous function
anti-acetylcholine receptor antibody
transferrin

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

intraclanial hypotension

Key exclusion criteria

traffic accident

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Nobuo
Middle name
Last name Araki

Organization

Saitama Medical University Faculty of medicine

Division name

Department of Neurology

Zip code

350-0495

Address

38 Morohongou Moroyama Saitama

TEL

049-276-1209

Email

csfh@saitama-med.ac.jp


Public contact

Name of contact person

1st name Makiko
Middle name
Last name Hirayama

Organization

Saitama Medical University Faculty of Medicine

Division name

Department of Neurology

Zip code

350-0495

Address

38 Morohongou Moroyama Saitama

TEL

049-276-1209

Homepage URL


Email

csfh@saitama-med.ac.jp


Sponsor or person

Institute

Japan Agency for Medical Research and Development

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical University Hospital Institutional Review Board

Address

38 Morohongo Moroyama-machi Iruma-gun Saitama

Tel

049-276-1354

Email

hirb@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

埼玉医科大学病院(埼玉県)


Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 08 Day


Related information

URL releasing protocol

None

Publication of results

Unpublished


Result

URL related to results and publications

None

Number of participants that the trial has enrolled

33

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Antibody test analysis was delayed due to the earthquake of Kumamoto.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events

None

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 04 Month 01 Day

Date of IRB

2016 Year 09 Month 05 Day

Anticipated trial start date

2016 Year 09 Month 07 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry

2019 Year 06 Month 30 Day

Date trial data considered complete

2019 Year 06 Month 30 Day

Date analysis concluded

2021 Year 03 Month 31 Day


Other

Other related information

We will observe the patients who suffer from lumber puncture examinations


Management information

Registered date

2016 Year 09 Month 07 Day

Last modified on

2021 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024966


Research Plan
Registered date File name
2020/03/11 16-049計画書清書版.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name